< Back to search
Filter
1

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Location: Quebec
Sponsor: Jean-Mathieu Beauregard

Sex: Male

Age: 18+

Code: NCT06943495

Phase1, Recruiting

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

for
Prostate Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male

Age: 0+

Code: NCT07548164

Phase3, Recruiting

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

for
Prostate Cancer
Location: New York NY, Brooklyn NY
Sponsor: Weill Medical College of Cornell University

Sex: Male

Age: 18+

Code: NCT04946370

Phase1, Phase2, Recruiting

Improving Health Literacy in African-American Prostate Cancer Patients

for
Prostate Cancer
Location: Atlanta GA
Sponsor: Emory University

Sex: Male

Age: 25 - 70+

Code: NCT03322891

Recruiting

Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy

for
Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: Male

Age: 45+

Code: NCT06940271

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

for
Elderly, Prostate Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: Male

Age: 70+

Code: NCT06824818

Recruiting

Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer

for
Prostate Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: Male

Age: 18+

Code: NCT06990542

Phase2, Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Lake Success NY, East Brunswick NJ, Fairfax VA,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18 - 70+

Code: NCT07540572

Phase1, Recruiting

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

for
Castrate Resistance Prostate Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18 - 70+

Code: NCT06927635

Phase2, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Boston MA, Hartford CT, The Bronx NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Boston MA, New York NY, Cleveland OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06465069

Phase1, Recruiting

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

for
Renal Cell Carcinoma, Urothelial Carcinoma,
Location: Boston MA, Philadelphia PA, Cleveland OH, Ann Arbor MI,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06966024

Phase1, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

for
Prostate Cancer, Metabolic Syndrome, Obesity,
Location: London
Sponsor: Western University

Sex: Male

Age: 18+

Code: NCT05802121

Early_phase1, Recruiting

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT05840484

Recruiting

Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer

for
Prostate Cancer
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: Male

Age: 18+

Code: NCT04249154

Phase2, Recruiting

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

for
Prostate Cancer
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: Male

Age: 18+

Code: NCT07011342

Recruiting

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT05873192

Phase2, Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

for
Prostatic Neoplasms
Location: New York NY, Sarasota FL, Cleveland OH, Seattle WA
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07082920

Phase1, Recruiting

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

for
Diabetes, Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06759701

Early_phase1, Recruiting